Thomas H Aasen - Net Worth and Insider Trading
Thomas H Aasen Net Worth
The estimated net worth of Thomas H Aasen is at least $427,833 dollars as of 2024-11-13. Thomas H Aasen is the EXEC VP, CFO AND CBO of ACADIA Pharmaceuticals Inc and owns about 23,848 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $427,833. Details can be seen in Thomas H Aasen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas H Aasen has not made any transactions after 2014-04-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thomas H Aasen
Thomas H Aasen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas H Aasen owns 2 companies in total, including Avalo Therapeutics Inc (AVTX) , and ACADIA Pharmaceuticals Inc (ACAD) .
Click here to see the complete history of Thomas H Aasen’s form 4 insider trades.
Insider Ownership Summary of Thomas H Aasen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVTX | Avalo Therapeutics Inc | 2016-01-10 | director |
| ACAD | ACADIA Pharmaceuticals Inc | 2014-04-04 | Vice Pres. & CFO & Treas. & Sec. |
Thomas H Aasen Latest Holdings Summary
Thomas H Aasen currently owns a total of 1 stock. Thomas H Aasen owns 23,848 shares of ACADIA Pharmaceuticals Inc (ACAD) as of April 4, 2014, with a value of $427,833.
Latest Holdings of Thomas H Aasen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2014-04-04 | 23,848 | 17.94 | 427,833 |
Holding Weightings of Thomas H Aasen
Thomas H Aasen Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas H Aasen has made a total of 0 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 15,000 shares on April 4, 2014, which brought Thomas H Aasen around $337,200.
Insider Trading History of Thomas H Aasen
- 1
Thomas H Aasen Trading Performance
Thomas H Aasen Ownership Network
Ownership Network List of Thomas H Aasen
Ownership Network Relation of Thomas H Aasen
Thomas H Aasen Owned Company Details
What does Avalo Therapeutics Inc do?
Who are the key executives at Avalo Therapeutics Inc?
Thomas H Aasen is the director of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .
Avalo Therapeutics Inc (AVTX) Insider Trades Summary
Over the past 18 months, Thomas H Aasen made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 74,840 shares made by Caissa Capital Management Ltd. , a net sale of 3,683,542 shares made by Armistice Capital Master Fund Ltd. , and a net purchase of 4,000 shares made by Garry Arthur Neil .
In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc (AVTX) were sold and 331 shares were bought by its insiders, resulting in a net sale of 15,017 shares.
Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avalo Therapeutics Inc Insider Transactions
Thomas H Aasen Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas H Aasen. You might contact Thomas H Aasen via mailing address: 3911 Sorrento Valley Boulevard, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
